Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 11/20/2020

Summary

Egan Dwight H, listed as a director and Chief Executive Officer, files this Form 4 for Co-Diagnostics, Inc. It reports exercises (code M) of a Non-Qualified Stock Option at $1.1 for 20,000 shares on November 20, 2020, 80,000 on November 23 and 50,000 on November 24, each followed by shares withheld (code F) and a sale (code S) of the remainder at $11.09, $10.44 and $10.51. A footnote says the option was granted September 3, 2019 under the 2015 Long-Term Incentive Plan, as amended, for up to 150,000 shares. The form also reports 75,000 Restricted Stock Units granted November 23, 2020, vesting in 6 equal installments, and is signed /s/ Dwight H. Egan on November 25, 2020.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Form 4: Co-Diagnostics, Inc. (CODX), Egan Dwight H, transaction 11/20/2020.” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-codx-4-filed2020-11-25-0001493152-20-022499-c705cfcc3e/, SHA-256 fbe55e57294e1f0ead17815a7f7330968c2d3fc1fe73bc4408ce982123a45584.

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Egan Dwight H (Last) (First) (Middle) 2401 S. FOOTHILL DRIVE SUITE D (Street) SALT LAKE CITY UT 84109 (City) (State) (Zip) | Egan Dwight H | (Last) | (First) | (Middle) | 2401 S. FOOTHILL DRIVE SUITE D | SALT LAKE CITY | UT | 84109 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Co-Diagnostics, Inc. [ CODX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Executive Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 11/20/2020
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 11/20/2020 | M | 20,000 | A | $ 1.1 | 20,000 | D
Common Stock | 11/20/2020 | F | 1,983 (2) | D | $ 1.1 | 18,017 | D
Common Stock | 11/20/2020 | S | 18,017 (3) | D | $ 11.09 | 0 | D
Common Stock | 11/23/2020 | M | 80,000 | A | $ 1.1 | 80,000 | D
Common Stock | 11/23/2020 | F | 8,431 (2) | D | $ 1.1 | 71,569 | D
Common Stock | 11/23/2020 | S | 71,569 (6) | D | $ 10.44 | 0 | D
Common Stock | 11/24/2020 | M | 50,000 | A | $ 1.1 | 50,000 | D
Common Stock | 11/24/2020 | F | 5,236 (2) | D | $ 1.1 | 44,764 | D
Common Stock | 11/24/2020 | S | 44,764 (7) | D | $ 10.51 | 0 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Non-Qualified Stock Option (right to buy) | $ 1.1 | 11/20/2020 (1) | M | 20,000 | (2) | 09/02/2029 | Common Stock | 20,000 | $ 0.00 | 130,000 | D
Non-Qualified Stock Option (right to buy) | $ 1.1 | 11/23/2020 (1) | M | 80,000 | (2) | 09/02/2029 | Common Stock | 80,000 | $ 0.00 | 50,000 | D
Non-Qualified Stock Option (right to buy) | $ 1.1 | 11/24/2020 (1) | M | 50,000 | (2) | 09/02/2029 | Common Stock | 50,000 | $ 0.00 | 0 | D
Restricted Stock Units | (4) | 11/23/2020 | A | 75,000 | (5) | (5) | Common Stock | 75,000 | $ 0.00 | 75,000 | D
Explanation of Responses:
1. Non-Qualified Stock Option granted to Reporting Person on September 3, 2019 pursuant to the Issuer's 2015 Long-Term Incentive Plan, as amended, to purchase up to 150,000 shares of common stock of the Issuer and previously reported on a Form 4 filed with the Commission on November 18, 2019.
2. All of the Options have vested.
3. Reflects 1,986 shares withheld by the Issuer at the market price of $11.09 per share less the exercise price of $1.10 per share to fund the cashless exercise of 20,000 options owned by the Reporting Person.
4. Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's common stock.
5. RSU vests in equal installments in 6 equal installments commencing on the six month anniversary of the date of grant and every six months thereafter.
6. Reflects 8,431 shares withheld by the Issuer at the market price of $10.44 per share less the exercise price of $1.10 per share to fund the cashless exercise of 80,000 options owned by the Reporting Person.
7. Reflects 5,236 shares withheld by the Issuer at the market price of $10.51 per share less the exercise price of $1.10 per share to fund the cashless exercise of 50,000 options owned by the Reporting Person.
/s/ Dwight H. Egan | 11/25/2020
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File: SEC_CODX_4_filed2020-11-25_0001493152-20-022499.xml
Size: 26,319 bytes
SHA-256: fbe55e57294e1f0ead17815a7f7330968c2d3fc1fe73bc4408ce982123a45584
Our copy: SEC_CODX_4_filed2020-11-25_0001493152-20-022499.xml
Original: www.sec.gov